Howard Krass

Howard Krass is the Founder and CEO of IPD Analytics, an industry leader in drug life-cycle insights, with a focus on analyzing competitive shifts in the pharmaceutical and biologic markets. Under Howard Krass's leadership, IPD Analytics provides subscription-based access to proprietary solutions that deliver actionable insights, including life-cycle analysis and market forecasts. Additionally, Howard Krass founded and leads IPD Capital, LLC, which specializes in companies leveraging strong intellectual property strategies. Earlier in their career, Howard Krass served as an Associate at Nortman & Bloom, P.A. Education includes a JD from The University of Texas School of Law and a bachelor's degree from The University of Texas at Austin, with earlier studies at the University of Michigan.